1015 Capital Partners’s Sanofi SNY Stock Holding History

1015 Capital Partners’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-140	Closed	-$6.78K	–	625
2025 Q4	$6.78K	Buy	+140	New	+$6.94K	0.01%	246

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

1015 Capital Partners's SNY Position: Q1 2026 in Review

1015 Capital Partners sold out of Sanofi (SNY) in Q1 2026, closing a stake of 140 shares — an estimated $6.78K sold.

1015 Capital Partners first reported a position in SNY in Q4 2025 and held it in 1 quarter. The position peaked at $6.78K in Q4 2025. 744 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

1015 Capital Partners reported no remaining Sanofi position as of Q1 2026 after selling out during the quarter.
1015 Capital Partners sold 140 Sanofi shares in Q1 2026, an estimated $6.78K.
1015 Capital Partners first reported a position in Sanofi in Q4 2025 and held it in 1 quarter.
1015 Capital Partners's Sanofi position peaked at $6.78K in Q4 2025.
744 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on 1015 Capital Partners's 13F filing for Q1 2026, filed 11 May 2026.